<?xml version="1.0" encoding="UTF-8" standalone="yes"?>
<References xsi:schemaLocation="http://www.iedb.org/schema/CurationSchema http://beta.iedb.org/schema/Curation.xsd" xmlns="http://www.iedb.org/schema/CurationSchema" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <Reference>
        <ReferenceId>315004</ReferenceId>
        <DateLastUpdated>2020-09-10-07:00</DateLastUpdated>
        <Article>
            <PubmedId>1375272</PubmedId>
            <Abstract>Peptide fragments of foreign and self-proteins are of great immunologic importance as their binding to major histocompatibility complex (MHC) class I or II molecules makes an interaction with a corresponding T cell receptor possible. Recently, allele-specific peptide sequence motifs proved to be responsible for MHC binding, no matter whether self- or non-self-antigens were involved. Up to now, all investigated human class II-associated peptides were derived from foreign antigenic proteins. Therefore, we undertook sequence and binding analyses with a 16-mer self-peptide (SP3) that has been eluted from HLA-DR1. Here we demonstrate, by synthetic polyalanine-based 13-mer analogues of SP3, that two bulky hydrophobic anchor residues with relative spacing i, i + 8 are sufficient for high affinity binding. This is consistent with the hydrophobic i, i + 8 binding pattern recently found for DR-restricted T cell epitopes. Nevertheless, highly helical alanine-based design peptides with anchor spacing i, i + 9 exhibit maximal affinity, whereas replacement of alanine by helix destabilizing proline abrogates binding. Thus, a two-residue contact motif is the common minimal requirement of self- and foreign peptides for high affinity anchoring to HLA-DR1. In contrast to class I, the anchor spacing of DR1-associated peptides seems to bear some variability due to conformational diversity.</Abstract>
            <ArticleYear>1992</ArticleYear>
            <ArticlePages>1799-803</ArticlePages>
            <ArticleTitle>Self-peptide released from class II HLA-DR1 exhibits a hydrophobic two-residue contact motif.</ArticleTitle>
            <Authors>
                <Author>
                    <LastName>Kropshofer</LastName>
                    <ForeName>H</ForeName>
                </Author>
                <Author>
                    <LastName>Max</LastName>
                    <ForeName>H</ForeName>
                </Author>
                <Author>
                    <LastName>Müller</LastName>
                    <ForeName>C A</ForeName>
                </Author>
                <Author>
                    <LastName>Hesse</LastName>
                    <ForeName>F</ForeName>
                </Author>
                <Author>
                    <LastName>Stevanovic</LastName>
                    <ForeName>S</ForeName>
                </Author>
                <Author>
                    <LastName>Jung</LastName>
                    <ForeName>G</ForeName>
                </Author>
                <Author>
                    <LastName>Kalbacher</LastName>
                    <ForeName>H</ForeName>
                </Author>
            </Authors>
            <Affiliations>Medical Research Center, University of Tübingen, Germany.</Affiliations>
            <ArticleChemicalList>Epitopes;HLA-DR1 Antigen;Peptide Fragments;Receptors, Antigen, T-Cell</ArticleChemicalList>
            <ArticleMeshHeadingsList>Amino Acid Sequence; Cell Line, Transformed; Epitopes(analysis); HLA-DR1 Antigen(chemistry; metabolism); Herpesvirus 4, Human(genetics); Humans; Kinetics; Major Histocompatibility Complex; Molecular Sequence Data; Peptide Fragments(chemistry; metabolism); Protein Binding; Receptors, Antigen, T-Cell(metabolism); Sequence Homology, Nucleic Acid; T-Lymphocytes(immunology)</ArticleMeshHeadingsList>
            <Comments>Data originally imported from the Database of Functional Molecular Immunology, FIMM (http://sdmc.lit.org.sg:8080/fimm/) and from the HLA Ligand Database (http://hlaligand.ouhsc.edu/)</Comments>
            <Journal>
                <Volume>175</Volume>
                <Issue>6</Issue>
                <Title>The Journal of experimental medicine</Title>
                <Issn>0022-1007</Issn>
                <MedlineTa>J Exp Med</MedlineTa>
            </Journal>
        </Article>
        <Epitopes>
            <Epitope>
                <EpitopeName>Self peptide SP3</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>AILEFRAMAQFSRKTD</LinearSequence>
                        <SourceMolecule>
                            <IedbAccession>SRC250726</IedbAccession>
                        </SourceMolecule>
                        <SourceOrganismId>9606</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table 1</LocationOfData>
                <EpitopeId>1988</EpitopeId>
                <EpitopeEvidenceCode>Internal Identifier-no external match available</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>The following refers to the epitope id as found in the original FIMM database: P000693.</EpitopeComments>
                <Assays>
                    <MhcLigandElution>
                        <LocationOfData>Figure 1</LocationOfData>
                        <MhcLigandElutionId>315014</MhcLigandElutionId>
                        <HostOrganism>
                            <OrganismId>9606</OrganismId>
                        </HostOrganism>
                        <InVivoProcess>
                            <InVivoProcessType>No immunization</InVivoProcessType>
                        </InVivoProcess>
                        <MhcLigand>
                            <MhcLigandObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>AILEFRAMAQFSRKTD</LinearSequence>
                                        <SourceMolecule>
                                            <IedbAccession>SRC250726</IedbAccession>
                                        </SourceMolecule>
                                        <SourceOrganismId>9606</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </MhcLigandObject>
                        </MhcLigand>
                        <AntigenPresentingCells>
                            <CellTissueType>Lymphoid</CellTissueType>
                            <CellType>B cell</CellType>
                            <CellCultureConditions>Cell Line / Clone (EBV transformed, B-LCL)</CellCultureConditions>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>52</MhcAlleleId>
                            <MhcEvidenceCode>Antibody purification</MhcEvidenceCode>
                        </MhcAllele>
                        <AssayInformation>
                            <AssayTypeId>252</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>The epitope was eluted from detergent-solubilzed HLA-DR1 from the EBV- transformed homozygous cell line WT-100 and sequenced. The HPLC profile of the eluted epitope was identical to that of the synthetic epitope.</AssayComments>
                        </AssayInformation>
                    </MhcLigandElution>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 2</LocationOfData>
                        <MhcBindingId>1376498</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>278</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>The N-terminally fluorescently labeled epitope bound to HLA-DRB1*0101 with high affinity.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>52</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 2</LocationOfData>
                        <MhcBindingId>1376504</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>278</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>The N-terminally fluorescently labeled epitope did not bind significantly to HLA-DQw5.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>88</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>IM (18-29)</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>GPLKAEIAQRLE</LinearSequence>
                        <StartingPosition>18</StartingPosition>
                        <EndingPosition>29</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P03485.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>11320</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table 1</LocationOfData>
                <EpitopeId>21686</EpitopeId>
                <ReferenceStartingPosition>18</ReferenceStartingPosition>
                <ReferenceEndingPosition>29</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Representative selection</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>The sequence is found in multiple strains of Influenza A virus.</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 2</LocationOfData>
                        <MhcBindingId>1376501</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>278</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>The N-terminally fluorescently labeled epitope bound to HLA-DRB1*0101 with low affinity.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>52</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>SP3 (1-9)</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>AILEFRAMA</LinearSequence>
                        <SourceMolecule>
                            <IedbAccession>SRC250726</IedbAccession>
                        </SourceMolecule>
                        <SourceOrganismId>9606</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table 1</LocationOfData>
                <EpitopeId>1987</EpitopeId>
                <EpitopeEvidenceCode>Internal Identifier-no external match available</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 2</LocationOfData>
                        <MhcBindingId>1376503</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>278</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>The N-terminally fluorescently labeled epitope did not bind significantly to HLA-DRB1*0101.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>52</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>AL(A)&lt;sub&gt;10&lt;/sub&gt;K</EpitopeName>
                <EpitopeStructure>
                    <SequenceMoleculeNoNaturalSource>
                        <ChemicalType>Peptide, no natural source</ChemicalType>
                        <LinearSequence>ALAAAAAAAAAAK</LinearSequence>
                    </SequenceMoleculeNoNaturalSource>
                </EpitopeStructure>
                <LocationOfData>Figure 3</LocationOfData>
                <EpitopeId>2355</EpitopeId>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 3</LocationOfData>
                        <MhcBindingId>1376505</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>295</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>The epitope did not compete the binding of SP3 (AILEFRAMAQFSRKTD) to HLA-DRB1*0101.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>52</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>AL(A)&lt;sub&gt;9&lt;/sub&gt;FK</EpitopeName>
                <EpitopeStructure>
                    <SequenceMoleculeNoNaturalSource>
                        <ChemicalType>Peptide, no natural source</ChemicalType>
                        <LinearSequence>ALAAAAAAAAAFK</LinearSequence>
                    </SequenceMoleculeNoNaturalSource>
                </EpitopeStructure>
                <LocationOfData>Figure 3</LocationOfData>
                <EpitopeId>2356</EpitopeId>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 3</LocationOfData>
                        <MhcBindingId>1376514</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>295</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>The epitope partially competed the binding of SP3 (AILEFRAMAQFSRKTD) to HLA-DRB1*0101.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>52</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>AL(A)&lt;sub&gt;8&lt;/sub&gt;FAK</EpitopeName>
                <EpitopeStructure>
                    <SequenceMoleculeNoNaturalSource>
                        <ChemicalType>Peptide, no natural source</ChemicalType>
                        <LinearSequence>ALAAAAAAAAFAK</LinearSequence>
                    </SequenceMoleculeNoNaturalSource>
                </EpitopeStructure>
                <LocationOfData>Figure 3</LocationOfData>
                <EpitopeId>2357</EpitopeId>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 3</LocationOfData>
                        <MhcBindingId>1376515</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>295</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>The epitope strongly competed the binding of SP3 (AILEFRAMAQFSRKTD) to HLA-DRB1*0101.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>52</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>F8</EpitopeName>
                <EpitopeStructure>
                    <SequenceMoleculeNoNaturalSource>
                        <ChemicalType>Peptide, no natural source</ChemicalType>
                        <LinearSequence>ALAAAAAAAFAAK</LinearSequence>
                    </SequenceMoleculeNoNaturalSource>
                </EpitopeStructure>
                <LocationOfData>Figure 3</LocationOfData>
                <EpitopeId>2358</EpitopeId>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 3</LocationOfData>
                        <MhcBindingId>1376516</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>295</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>The epitope strongly competed the binding of SP3 (AILEFRAMAQFSRKTD) to HLA-DRB1*0101.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>52</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>AL(PA)&lt;sub&gt;3&lt;/sub&gt;FAAK</EpitopeName>
                <EpitopeStructure>
                    <SequenceMoleculeNoNaturalSource>
                        <ChemicalType>Peptide, no natural source</ChemicalType>
                        <LinearSequence>ALAPAPAPAFAAK</LinearSequence>
                    </SequenceMoleculeNoNaturalSource>
                </EpitopeStructure>
                <LocationOfData>Figure 3</LocationOfData>
                <EpitopeId>2440</EpitopeId>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 3</LocationOfData>
                        <MhcBindingId>1376517</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>295</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>The epitope did not compete the binding of SP3 (AILEFRAMAQFSRKTD) to HLA-DRB1*0101.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>52</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>F7</EpitopeName>
                <EpitopeStructure>
                    <SequenceMoleculeNoNaturalSource>
                        <ChemicalType>Peptide, no natural source</ChemicalType>
                        <LinearSequence>ALAAAAAAFAAAK</LinearSequence>
                    </SequenceMoleculeNoNaturalSource>
                </EpitopeStructure>
                <LocationOfData>Figure 3</LocationOfData>
                <EpitopeId>2360</EpitopeId>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 3</LocationOfData>
                        <MhcBindingId>1376518</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>295</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>The epitope partially competed the binding of SP3 (AILEFRAMAQFSRKTD) to HLA-DRB1*0101.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>52</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>F6</EpitopeName>
                <EpitopeStructure>
                    <SequenceMoleculeNoNaturalSource>
                        <ChemicalType>Peptide, no natural source</ChemicalType>
                        <LinearSequence>ALAAAAAFAAAAK</LinearSequence>
                    </SequenceMoleculeNoNaturalSource>
                </EpitopeStructure>
                <LocationOfData>Figure 3</LocationOfData>
                <EpitopeId>2362</EpitopeId>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 3</LocationOfData>
                        <MhcBindingId>1376519</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>295</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>The epitope did not compete the binding of SP3 (AILEFRAMAQFSRKTD) to HLA-DRB1*0101.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>52</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>(A)&lt;sub&gt;9&lt;/sub&gt;FAAK</EpitopeName>
                <EpitopeStructure>
                    <SequenceMoleculeNoNaturalSource>
                        <ChemicalType>Peptide, no natural source</ChemicalType>
                        <LinearSequence>AAAAAAAAAFAAK</LinearSequence>
                    </SequenceMoleculeNoNaturalSource>
                </EpitopeStructure>
                <LocationOfData>Figure 3</LocationOfData>
                <EpitopeId>5</EpitopeId>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 3</LocationOfData>
                        <MhcBindingId>1376520</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>295</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>The epitope did not compete the binding of SP3 (AILEFRAMAQFSRKTD) to HLA-DRB1*0101.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>52</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
        </Epitopes>
    </Reference>
</References>

